Afuco™ Anti-Human PTH ADCC Therapeutic Antibody (ABX-PTH), ADCC Enhanced
Anti-PTH ADCC Enhanced Antibody (ABX-PTH) is an ADCC enhanced antibody produced by our Afuco™ platform. The fully human monoclonal antibody that targets and neutralizes the action of parathyroid hormone (PTH). ABX-PTH is being developed for the treatment of secondary hyperparathyroidism (SHPT) which is frequently observed in patients with chronic kidney disease. Preclinical studies demonstrate ABX-PTH to be highly potent in in vivo models of SHPT.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-690CL |
| Pricing | Inquiry |
| Host | Human |
| Target | PTH |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |